Financial Highlights
Transition of consolidated financial results of the past 5 years
* Fiscal years ended March 31.
1. Consolidated management performance
| FY ended Mar. 31, 2014 |
FY ended Mar. 31, 2015 |
FY ended Mar. 31, 2016 |
FY ended Mar. 31, 2017 |
FY ended Mar. 31, 2018 |
||
|---|---|---|---|---|---|---|
| Net sales (¥ Million) | 18,510 | 18,758 | 18,859 | 19,194 | 20,350 | |
| Medical Instrument Division (¥ Million) | 11,293 | 11,121 | 11,345 | 11,373 | 11,537 | |
| Environmental Instrument Division (¥ Million) | 7,216 | 7,636 | 7,513 | 7,820 | 8,813 | |
| Operating income (¥ Million) | 2,191 | 2,332 | 2,268 | 1,867 | 2,572 | |
| Medical Instrument Division (¥ Million) | 1,450 | 1,254 | 1,496 | 1,000 | 915 | |
| Environmental Instrument Division (¥ Million) | 741 | 1,077 | 772 | 866 | 1,656 | |
| Ordinary income (¥ Million) | 2,241 | 2,413 | 2,370 | 1,957 | 2,651 | |
| Net income (¥ Million) | 1,316 | 1,427 | 1,594 | 1,480 | 1,887 | |
| Net income per share (J¥) | 112.45 | 117.47 | 129.99 | 114.72 | 153.76 | |
| Return on equity (%) | 9.8 | 9.5 | 9.7 | 8.0 | 10.1 | |
| Return on assets (%) | 9.3 | 9.5 | 9.2 | 7.6 | 9.9 | |
| Operating margin (%) | 11.8 | 12.4 | 12.0 | 9.7 | 12.6 | |
2. Consolidated financial position
| FY ended Mar. 31, 2014 |
FY ended Mar. 31, 2015 |
FY ended Mar. 31, 2016 |
FY ended Mar. 31, 2017 |
FY ended Mar. 31, 2018 |
|
|---|---|---|---|---|---|
| Total assets (¥ Million) | 25,000 | 25,691 | 25,677 | 25,919 | 27,795 |
| Net assets (¥ Million) | 14,619 | 15,685 | 17,039 | 17,962 | 19,572 |
| Equity ratio (%) | 58.4 | 61.0 | 66.4 | 69.3 | 70.4 |
| Book-value per share (¥) | 1,205.37 | 1,285.48 | 1,387.86 | 1,463.04 | 1,594.19 |
3. Consolidated condition of cash flows
(¥ Million)
| FY ended Mar. 31, 2014 |
FY ended Mar. 31, 2015 |
FY ended Mar. 31, 2016 |
FY ended Mar. 31, 2017 |
FY ended Mar. 31, 2018 |
|
|---|---|---|---|---|---|
| Cash flows from operating activities | 1,678 | 1,457 | 2,142 | 2,168 | 1,920 |
| Cash flows from investing activities | ∆827 | ∆1,183 | ∆536 | ∆562 | ∆695 |
| Cash flows from financing activities | ∆451 | ∆588 | ∆1,274 | ∆990 | ∆816 |
| Cash and cash equivalents at end of year | 2,781 | 2,466 | 2,798 | 3,479 | 3,888 |